Pfizer vaccine

Pfizer and Biontech Announce Publication of Results from Landmark phase 3 Trial of BNT162B2 COVID-19 vaccine

December 10, 2020

The FINANCIAL --Pfizer and Biontech Announce Publication of Results from Landmark phase 3 Trial of BNT162B2 COVID-19 vaccine Candidate in the New England Journal of Medicine

Pfizer and BioNTech coronavirus vaccine candidate found to be more than 90% effective

The FINANCIAL — Pfizer Inc. and BioNTech SE (Nasdaq: BNTX) today announced

by The FINANCIAL

November 9, 2020

3 mins read

Go toTop

Pfizer vaccine

Pfizer and Biontech Announce Publication of Results from Landmark phase 3 Trial of BNT162B2 COVID-19 vaccine

Pfizer and BioNTech coronavirus vaccine candidate found to be more than 90% effective

Popular Posts

Natali Safaryan – The Voice of Armenia on the International Stage

We Are Proud of Every Jury Member”: Mykyta Harmel and the Global Mission of Golden Time Talent

By 41% to 30% public say government right to u-turn on welfare

Sean Combs Trial: A High-Profile Case Ends in Mixed Verdict, Exposing Prosecutorial Missteps

International Festival of Arts and Talents in London: World Talent Award 2025

Modern bathroom that you will be proud of having it

Artificial intelligence powers record-breaking all-in-one miniature spectrometers

Poverty rate in India was slashed, says report, but globally 1.2bn still poor

Food industry shows ‘stalled progress’ to reduce salt intakes

Depressed people are just more realistic, right? Not so, says UC Berkeley study

Recent Posts

Get updates

Join

Latest comments

Suggestions

Pfizer vaccine

Popular Posts

Recent Posts

Get updates

Join

Latest comments